According to AstraZeneca's latest financial reports the company's current EPS (TTM) is $3.35. In 2022 the company made an earnings per share (EPS) of $1.79 an increase over its 2021 EPS that were of $0.24.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $3.27 | 82.64% |
2022 | $1.79 | 631.03% |
2021 | $0.24 | -88.11% |
2020 | $2.06 | 136.89% |
2019 | $0.87 | -39.41% |
2018 | $1.44 | -28.27% |
2017 | $2.00 | -14.37% |
2016 | $2.34 | 24.11% |
2015 | $1.88 | 127.55% |
2014 | $0.83 | -51.96% |
2013 | $1.72 | -58.95% |
2012 | $4.20 | -32.2% |
2011 | $6.19 | 30.89% |
2010 | $4.73 | 7.9% |
2009 | $4.38 | 23.57% |
2008 | $3.55 | 12.3% |
2007 | $3.16 | -3.11% |
2006 | $3.26 | 32.65% |
2005 | $2.46 | -94.03% |
2004 | $41.13 | 2651.98% |
2003 | $1.49 | 7.93% |
2002 | $1.38 | 1.32% |
2001 | $1.37 | 12.88% |
2000 | $1.21 | 120.59% |
1999 | $0.55 | -76.51% |
1998 | $2.34 | 1412.8% |
1997 | $0.15 | -88.43% |
1996 | $1.33 |